Kathryn Webert

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia
    Kathryn E Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfusion 52:2466-74; quiz 2465. 2012
  2. ncbi Low prevalence of inhibitor antibodies in the Canadian haemophilia population
    K E Webert
    Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Haemophilia 18:e254-9. 2012
  3. ncbi Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies
    Kathryn E Webert
    Medical, Scientific, and Research Affairs, Canadian Blood Services, Hamilton, Edmonton and Toronto, Canada
    Transfus Med Rev 22:1-34. 2008
  4. ncbi A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation
    Kathryn E Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfusion 48:81-91. 2008
  5. ncbi Randomization in clinical trials
    Kathryn E Webert
    Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada
    Transfusion 47:1753-4. 2007
  6. ncbi Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia
    K E Webert
    Division of Hematology, Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada
    Haemophilia 13:518-26. 2007
  7. ncbi Treatment allocation in clinical trials
    Kathryn E Webert
    Department of Medicine, McMaster University, and Canadian Blood Services, Hamilton, Ontario, Canada
    Transfusion 47:2187-8. 2007
  8. ncbi A study of the agreement between patient self-assessment and study personnel assessment of bleeding symptoms
    Kathryn E Webert
    McMaster University, Hamilton, Ontario, Canada
    Transfusion 46:1926-33. 2006
  9. ncbi The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia
    Kathryn Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Haematologica 91:1530-7. 2006
  10. ncbi A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura
    Kathryn E Webert
    Department of Medicine, McMaster University, Rm HSC 3N43, 1200 Main St W, Hamilton, ON, Canada L8N 3Z5
    Blood 102:4306-11. 2003

Detail Information

Publications29

  1. ncbi A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia
    Kathryn E Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfusion 52:2466-74; quiz 2465. 2012
    ..The aim of this study was to develop a simple, valid, and reliable measurement tool to categorize the severity of bleeding in patients with chemotherapy-induced thrombocytopenia (CIT)...
  2. ncbi Low prevalence of inhibitor antibodies in the Canadian haemophilia population
    K E Webert
    Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Haemophilia 18:e254-9. 2012
    ..The classification system used in this study was easy for clinics to apply and was important in defining the population with inhibitors...
  3. ncbi Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies
    Kathryn E Webert
    Medical, Scientific, and Research Affairs, Canadian Blood Services, Hamilton, Edmonton and Toronto, Canada
    Transfus Med Rev 22:1-34. 2008
    ..These proceedings are provided to make available to the transfusion medicine community the considerable amount of important information presented at this consensus conference...
  4. ncbi A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation
    Kathryn E Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfusion 48:81-91. 2008
    ..Anemia may be an important factor contributing to an increased risk of bleeding, particularly in patients with thrombocytopenia...
  5. ncbi Randomization in clinical trials
    Kathryn E Webert
    Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada
    Transfusion 47:1753-4. 2007
  6. ncbi Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia
    K E Webert
    Division of Hematology, Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada
    Haemophilia 13:518-26. 2007
    ..The tracking system used in this study is a valuable tool to describe ongoing utilization patterns of rFVIIa...
  7. ncbi Treatment allocation in clinical trials
    Kathryn E Webert
    Department of Medicine, McMaster University, and Canadian Blood Services, Hamilton, Ontario, Canada
    Transfusion 47:2187-8. 2007
  8. ncbi A study of the agreement between patient self-assessment and study personnel assessment of bleeding symptoms
    Kathryn E Webert
    McMaster University, Hamilton, Ontario, Canada
    Transfusion 46:1926-33. 2006
    ..These assessments are commonly performed by study personnel and can be time-consuming. The purpose of this study was to assess whether patients were able to reliably assess their bleeding status on a daily basis...
  9. ncbi The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia
    Kathryn Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Haematologica 91:1530-7. 2006
    ..Patients with acute myeloid leukemia are at risk of bleeding. The risk factors for different severities of bleeding are poorly studied...
  10. ncbi A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura
    Kathryn E Webert
    Department of Medicine, McMaster University, Rm HSC 3N43, 1200 Main St W, Hamilton, ON, Canada L8N 3Z5
    Blood 102:4306-11. 2003
    ..6%) required treatment for hemostatic impairment. Two fetal deaths occurred. One was caused by hemorrhage. ITP in pregnancy carries a low risk, but mothers and infants may require therapy to raise their platelet counts...
  11. ncbi A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia
    Nancy M Heddle
    Department of Medicine, McMaster University, Hamilton, ON, Canada
    Blood 113:1564-73. 2009
    ..Whether this finding was due to chance or represents a real difference requires further investigation. These clinical studies are registered on (http://www.clinicaltrials.gov) as NCT00420914...
  12. ncbi Do expert assessments converge? An exploratory case study of evaluating and managing a blood supply risk
    John Eyles
    School of Geography and Earth Sciences, McMaster University, 1280 Main St West, Hamilton, Ontario, Canada
    BMC Public Health 11:666. 2011
    ..It also describes the context of publicly funded blood transfusion in Canada and the withdrawal event that is the basis of this study...
  13. ncbi A policy informing qualitative study to improve the process of blood product recalls and withdrawals
    Nancy M Heddle
    Departments of Medicine and the School of Geography, and Earth Science, McMaster University, Hamilton, Ontario, Canada
    Transfusion 48:2585-95. 2008
    ..With the use of qualitative techniques and a modified grounded theory approach, the current process was mapped, issues were identified, and recommendations to improve the system were developed...
  14. ncbi An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts
    Catherine P M Hayward
    McMaster University and the Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada, L8N 3Z5
    Thromb Haemost 100:134-45. 2008
    ..The derived limits for thrombocytopenic samples provide guidance for evaluating thrombocytopenic platelet function disorders, including which agonists to test, based on the sample platelet count...
  15. ncbi Consequences of transfusion of platelet antibody: a case report and literature review
    Katerina Pavenski
    Department of Medicine, and the Department of Pathology and Laboratory Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfusion 48:1981-9. 2008
    ..Passive transfer of platelet (PLT) antibody by blood transfusion can lead to severe thrombocytopenia, bleeding, and an acute transfusion reaction...
  16. ncbi Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review
    Nancy M Heddle
    The Department of Medicine and the Department of Molecular Medicine and Pathology, McMaster University, Hamilton, Ontario, Canada
    Transfusion 48:1447-58. 2008
    ....
  17. ncbi Factors affecting the frequency of red blood cell outdates: an approach to establish benchmarking targets
    Nancy M Heddle
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfusion 49:219-26. 2009
    ..In this study, a provincial database of red blood cell (RBC) product inventory/disposition in hospitals was analyzed to identify factors that affected RBC outdates and to systematically establish optimal target levels for RBC outdates...
  18. ncbi Understanding the meaning of permanent deferral for blood donors
    Susan Whittaker
    Department of Medicine and the Department of Nursing, McMaster University, Hamilton, Ontario, Canada
    Transfusion 48:64-72. 2008
    ..The purpose of this study was to explore the permanent deferral experience from the donor's perspective...
  19. ncbi Proceedings of a consensus conference: the screening of blood donors for variant CJD
    Morris A Blajchman
    Canadian Blood Services, Hamilton, Ontario, Canada
    Transfus Med Rev 18:73-92. 2004
    ..This contentious issue is of potential considerable importance to transfusion medicine personnel worldwide, as well as to future recipients of allogeneic blood components...
  20. ncbi Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies
    Nancy M Heddle
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfusion 43:742-52. 2003
    ....
  21. ncbi Bleeding during critical illness: a prospective cohort study using a new measurement tool
    Donald M Arnold
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Clin Invest Med 30:E93-102. 2007
    ..To estimate the incidence, severity, duration and consequences of bleeding during critical illness, and to test the performance characteristics of a new bleeding assessment tool...
  22. ncbi Proceedings of a consensus conference: blood-borne HIV and hepatitis-optimizing the donor selection process
    Jo Anne Chiavetta
    Canadian Blood Services, HEMA QUEBEC, Canada
    Transfus Med Rev 17:1-30. 2003
    ....
  23. ncbi Transfusion-related acute lung injury
    Kathryn E Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfus Med Rev 17:252-62. 2003
    ..In this report, what is known about TRALI is summarized and some of the areas in which knowledge and/or consensus are currently lacking are identified...
  24. ncbi Proceedings of a consensus conference: towards an understanding of TRALI
    Mindy Goldman
    Canadian Blood Services, Medical, Scientific and Research Affairs, Ottawa, Ontario K1G 4J5, Canada
    Transfus Med Rev 19:2-31. 2005
    ....
  25. ncbi Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review
    Craig D Ainsworth
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfus Med Rev 23:155-9. 2009
    ..Passenger lymphocyte syndrome-associated hemolysis is occasionally severe as in our case, but can be effectively treated with compatible RBC transfusions...
  26. ncbi Transfusion-related acute lung injury
    Kathryn E Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Curr Opin Hematol 12:480-7. 2005
    ..SUMMARY: In this report, what is known about transfusion-related acute lung injury is summarized with particular emphasis on recent studies. Some of the areas in which knowledge and/or consensus are currently lacking are identified...
  27. ncbi Randomized trials in patients with blunt and penetrating trauma
    Kathryn E Webert
    J Trauma 60:242-3; author reply 243-4. 2006
  28. ncbi Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage
    Donald M Arnold
    Canadian Blood Services, Ontario, Canada
    Transfusion 44:1361-6. 2004
    ..CONCLUSION: Hypotensive reactions can occur with blood products that are LR before storage and non-LR ANH. An inherent defect in the metabolism of kinins may be a risk factor for the development of hypotensive transfusion reactions...
  29. ncbi On-label versus off-label use of recombinant activated factor VII: a comprehensive review of use in two Canadian centers
    Manuel D Carcao
    Division of Hematology Oncology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada
    Semin Hematol 45:S68-71. 2008
    ..It is important to be aware of the increasing use of rFVIIa in off-label indications...